Back to search

Switzerland· 68381001

Bilaxten 20 mg, Schmelztabletten

A bilastin product, registered in Switzerland by A. Menarini GmbH and dispensed under Swissmedic category D. The same ATC class is registered in 11 of our 19 countries.

Cat D (Swissmedic)ATC R06AX29

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedBilaxten 20 mg, SchmelztablettenATCR06AX29REGISTER NO.68381001PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Bilastin is registered in 11 of 19 countries.

Countries holding a registration under ATC R06AX29 (bilastin), each read from that country’s own register.

  • This record: Switzerland
  • 7 of them publish a price we can compare per daily dose

Bilastin · ATC R06AX29

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bilastin costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.14 in France to $0.45 in Switzerland — a ×3.3 gap.

  • Switzerland: $0.45 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Bilastin · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.45
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Manufacturer
A. Menarini GmbH
Country
Switzerland (CH)
ATC code
R06AX29
ATC class
Bilastin
Defined daily dose
20 mg, O
Swissmedic category
D
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fee0b8fe-1bd0-44c2-a41d-c13e1cfe3d1e
GET /v1/drugs/fee0b8fe-1bd0-44c2-a41d-c13e1cfe3d1e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about bilastin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.